InvestorsObserver
×
News Home

Will Acurx Pharmaceuticals Inc (ACXP) Outperform the Rest of the Stocks in the Healthcare Sector?

Monday, November 06, 2023 09:57 AM | InvestorsObserver Analysts

Mentioned in this article

Will Acurx Pharmaceuticals Inc (ACXP) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 94 puts Acurx Pharmaceuticals Inc (ACXP) near the top of the Healthcare sector according to InvestorsObserver. Acurx Pharmaceuticals Inc's score of 94 means that it ranks higher than 94% of stocks in the sector. In addition, its overall score of 52 ranks it higher than 52% of all stocks.

Overall Score - 52
ACXP has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on ACXP!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 52 would rank higher than 52 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Acurx Pharmaceuticals Inc Stock Today?

Acurx Pharmaceuticals Inc (ACXP) stock has fallen -9.76% while the S&P 500 has risen 0.14% as of 9:54 AM on Monday, Nov 6. ACXP is lower by -$0.32 from the previous closing price of $3.28 on volume of 152,127 shares. Over the past year the S&P 500 is up 14.64% while ACXP has risen 3.14%. ACXP lost -$1.13 per share the over the last 12 months. Click Here to get the full Stock Report for Acurx Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App